Kinnari Patel
President en ROCKET PHARMACEUTICALS, INC. .
Fortuna: 10 M $ al 31/03/2024
Perfil
Kinnari Patel's current job is as the President, Chief Operating Officer, and Head of R&D at Rocket Pharmaceuticals, Inc. He started this position in 2024.
Dr. Patel's former jobs include being the Head of US Risk Management at Bristol Myers Squibb Co. from 2010 to 2014, and the Chief Operating Officer & Head of Development at Rocket Pharmaceuticals Ltd.
from 2016 to 2021.
Dr. Patel's education history includes an undergraduate and doctorate degree from the University of the Sciences in Philadelphia, as well as an MBA from The Leonard N Stern School of Business.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
16/02/2024 | 378 903 ( 0.42% ) | 10 M $ | 31/03/2024 |
Cargos activos de Kinnari Patel
Empresas | Cargo | Inicio |
---|---|---|
ROCKET PHARMACEUTICALS, INC. | President | - |
Antiguos cargos conocidos de Kinnari Patel.
Empresas | Cargo | Fin |
---|---|---|
Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Chief Operating Officer | 01/02/2021 |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/04/2014 |
Formación de Kinnari Patel.
University of the Sciences in Philadelphia | Doctorate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
ROCKET PHARMACEUTICALS, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Kinnari Patel